Guelph, Ontario--Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) announced it will raise up to C$15 million in a marketed private placement that will dilute existing shareholders.
The company entered into an agreement with Red Cloud Securities Inc. to act as sole agent on a "best efforts" basis for the sale of up to 15,000,000 units at a price of C$1.00 per unit, according to a statement released Thursday.
Each unit consists of one common share and one warrant, which allows the holder to purchase an additional common share at C$1.50 for 36 months. The agent, Red Cloud, has an option to sell an additional 3,000,000 units, which could bring total gross proceeds to C$18 million.
The offering represents a significant capital infusion but also introduces dilution for current investors. The issuance of 15,000,000 new shares, plus the potential for 15,000,000 more from the warrants, will increase the total number of outstanding shares, potentially putting downward pressure on the stock price.
Zentek intends to use the net proceeds to advance its key projects. A significant portion will fund the development of the Albany Graphite Project, including a new Preliminary Economic Assessment and subsequent feasibility studies. Funds will also support the commercialization of its ZenGUARD™ platform and be used for general working capital.
The financing is expected to close on or about May 27, 2026, and is subject to regulatory approvals, including that of the TSX Venture Exchange.
The offering structure suggests the company is balancing its need for capital with market conditions. The C$1.00 offering price is a discount to recent trading, and the C$1.50 warrant exercise price provides potential future upside for investors if the company's projects advance successfully.
The capital raise is a critical step for Zentek as it seeks to advance its graphite and graphene-based technologies. The success of the Albany Graphite Project and the commercialization of ZenGUARD™ are now the key catalysts for the company's future performance.
This article is for informational purposes only and does not constitute investment advice.
